T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
1276
People Inc
PPLI
$2.99B
| $3.42M | ﹤0.01% |
82,649
-3,109,963
| -97% | -$151M |
|
|
CADE
1277
DELISTED
Cadence Bank
CADE
| $3.41M | ﹤0.01% |
160,448
-202,608
| -56% | -$4.57M |
|
1278
Amdocs
DOX
$6.21B
| $3.4M | ﹤0.01% |
40,280
+2,851
| +8% | +$258K |
|
1279
STAG Industrial
STAG
$7.1B
| $3.38M | ﹤0.01% |
97,945
+2,171
| +2% | +$78.8K |
|
1280
Glacier Bancorp
GBCI
$6.49B
| $3.38M | ﹤0.01% |
118,443
+4,046
| +4% | +$125K |
|
1281
Seacoast Banking Corp of Florida
SBCF
$3.49B
| $3.37M | ﹤0.01% |
153,582
-1,280
| -0.8% | -$30K |
|
1282
Arrow Electronics
ARW
$10.8B
| $3.37M | ﹤0.01% |
26,885
-210
| -0.8% | -$28K |
|
1283
New York Times
NYT
$10.5B
| $3.37M | ﹤0.01% |
81,685
+5,076
| +7% | +$214K |
|
1284
Boston Beer
SAM
$1.92B
| $3.35M | ﹤0.01% |
8,610
-399
| -4% | -$140K |
|
1285
Ingredion
INGR
$6.61B
| $3.35M | ﹤0.01% |
33,994
-581
| -2% | -$60.3K |
|
1286
Donaldson
DCI
$11.1B
| $3.34M | ﹤0.01% |
56,046
+2,720
| +5% | +$168K |
|
1287
Toll Brothers
TOL
$13.9B
| $3.33M | ﹤0.01% |
45,005
+2,982
| +7% | +$235K |
|
1288
Universal Display
OLED
$4.05B
| $3.32M | ﹤0.01% |
21,147
-350
| -2% | -$53.2K |
|
1289
Planet Fitness
PLNT
$3.83B
| $3.32M | ﹤0.01% |
67,433
-972,889
| -94% | -$58.9M |
|
1290
HealthEquity
HQY
$8.78B
| $3.31M | ﹤0.01% |
45,307
+2,325
| +5% | +$157K |
|
1291
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.42B
| $3.31M | ﹤0.01% |
155,887
+12,304
| +9% | +$296K |
|
1292
Prelude Therapeutics
PRLD
$425M
| $3.3M | ﹤0.01% |
1,066,858
-15,390
| -1% | -$57.7K |
|
1293
Monro
MNRO
$352M
| $3.29M | ﹤0.01% |
118,267
+20,795
| +21% | +$717K |
|
|
AMED
1294
DELISTED
Amedisys
AMED
| $3.28M | ﹤0.01% |
35,130
-193,051
| -85% | -$17.8M |
|
|
THRX
1295
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $3.27M | ﹤0.01% |
1,216,500
-39,509
| -3% | -$155K |
|
|
CIVI
1296
DELISTED
Civitas Resources
CIVI
| $3.26M | ﹤0.01% |
40,339
+4,053
| +11% | +$314K |
|
1297
Antero Resources
AR
$11.5B
| $3.25M | ﹤0.01% |
128,204
+1,802
| +1% | +$46.5K |
|
1298
Kratos Defense & Security Solutions
KTOS
$12B
| $3.24M | ﹤0.01% |
215,711
-1,372
| -0.6% | -$20.4K |
|
1299
MGE Energy Inc
MGEE
$3.09B
| $3.22M | ﹤0.01% |
47,058
+1,012
| +2% | +$76.8K |
|
1300
Mueller Industries
MLI
$14.6B
| $3.21M | ﹤0.01% |
170,972
+8,856
| +5% | +$175K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.